close

Enter

Log in using OpenID

Infertility Drugs Market

embed
In order to treat infertility problems among the population there are many dugs present in the market such as Clomiphene (Clomid), Letrozole (Femara), Gonadotropins, etc.
Infertility Drugs Market - Size, Share, Outlook, and
Opportunity Analysis, 2019 – 2026
Infertility is a global health issue as its affects both men and women. Infertility in females
occur due to increasing age, polycystic ovarian syndrome (PCOS), obesity, and multiple
miscarriages whereas in males infertility occur due to erectile dysfunction, low sperm count,
abnormal sperms, etc. Increasing prevalence of infertility is expected to propel demand for the
infertility drugs. According to World Health Organization (WHO) 2012 report, infertility affects
one out of four couples in emerging economies. Many researchers are working towards finding
an efficient treatment for the infertility. For instance, in 2018 at Ben-Gurion University (BGU),
Israel researchers were developing a new, single-dose infertility treatment based on a new
compound. The new treatment, developed by the BGU researchers, stimulates the expression of
the telomerase and re-elongates the telomeres, protecting the cells from damage.
Request Sample Copy of Research Report @ http://bit.ly/2W4lxIW
The global infertility drugs market size was valued at US$ 3.8 billion in 2017, and is expected
to witness a CAGR of 5.8% over the forecast period (2019 – 2026).
Increasing Research & Development for More Effective Treatment with Lesser Side-Effects to
Reduce Infertility is expected to Drive Growth of the Infertility Drugs Market
The infertility drugs market size is expected to witness significant growth, owing to the rising
research and developmental studies for more effective treatment to achieve pregnancy and live
births. For instance, in 2014, a team of researchers at National Institutes of Health’s (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
found that women treated with Letrozole have high rates of ovulation and live births than
women treated with the standard drug, Clomiphene. Furthermore, among women who received
Letrozole, 27.5% of them eventually had a live birth and women who received clomiphene,
only 19.1% them experienced a live birth. The cumulative ovulation rate was higher for the
Letrozole group, with ovulation occurring 61.7% of the time, and the women in the clomiphene
group ovulated 48.3% of the time.
Report includes chapters which deeply display the following deliverable about industry :
• Infertility Drugs Market Research Objective and Assumption
• Infertility Drugs Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Infertility Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Infertility Drugs Market, By Regions
• Infertility Drugs Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Infertility Drugs Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Infertility Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Infertility Drugs Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Increasing prevalence of infertility in couples is highly contributing to infertility drugs market
size. For instance, According to Centres for Disease Control and Prevention (CDC) report of
2018, about 6% of women aged 15 to 44 years in the U.S. were unable to get pregnant after
one year of trying (infertility). Also, about 12% of women aged 15 to 44 years in the U.S. have
difficulty getting pregnant or carrying a pregnancy to term. Infertility also affects rising number
of men. According to the same source, almost 9% of men aged 25 to 44 years in the U.S.
reported that they required medical help for reproduction.
Inquire Here Before Purchase of Research Report @ http://bit.ly/2Z1PvPH
Infertility Drugs Market - Competitive Landscape
Key players operating in the global infertility drugs market include Merck & Co., Ferring
Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus
Pharmaceuticals.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge366   documents Email
Document
Category
Health and Medicine
Views
2
File Size
109 KB
Tags
infertility, Infertility Drugs Market
1/--pages
Report inappropriate content